FDA’s Accelerated Approval Challenged, But Is it Fair to Blame the Agency?
In JAMA this week, an article raises doubts about the safety and effectiveness of drugs approved by FDA via the accelerated approval program but a critical review shows that despite the concerns raised, the regulatory pathway does its job as intended. Drugs and biologics intended for life-threatening or serious conditions can be approved based on … Read more
